Company intelligence / Profile preview

HLB PANAGENE Co., Ltd.

Daejeon, Daejeon, South Koreahlbpanagene.com ↗
Ownership
Private
Employees
~63
Development stage
Other
01

Overview

The company has developed and commercialized multiple diagnostic kits for cancer detection, including the PNAClamp NRAS Mutation Detection Kit for colorectal cancer and various liquid biopsy products.

Therapeutic areas
OncologyInfectious DiseasesNeurologyHematology
Modalities
PNA (Peptide Nucleic Acid)Molecular diagnostics
Industry
Molecular Diagnostics
02

Partnerships

ThermoFisher ScientificMerck SeronoAbnovaEurogentecAdvanDxDAKOCBC Japan

Beyond the preview

Go deeper on HLB PANAGENE Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLB PANAGENE Co., Ltd..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call